Lynx1 Capital Management LP
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1910456. Latest Form 4 filed Oct 26, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Korro Bio, Inc.KRRO | 10% owner | 4 | 2026-10-22 | 2026-10-26 |
Transactions: 4
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-26 | Korro Bio, Inc.10% owner | Purchase | 25,124 | $11.7454 | $295.1k | Form 4 |
| 2026-10-23 | Korro Bio, Inc.10% owner | Purchase | 2,510 | $12.1061 | $30.4k | Form 4 |
| 2026-10-22 | Korro Bio, Inc.10% owner | Purchase | 40,000 | $11.0366 | $441.5k | Form 4 |
| 2026-10-22 | Korro Bio, Inc.10% owner | Purchase | 12,175 | $9.6764 | $117.8k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 07:22 ET. Listed shows no prices and gives no investment advice.